Group 1 - The core point of the article is that Huajian Medical has agreed to acquire 6.23% of the shares of Chuangye Huikang, marking a strategic investment in the AI healthcare sector [1][2] - The acquisition involves purchasing 96.5251 million A-shares at a price of RMB 5.18 per share, totaling RMB 500 million [1] - Following the acquisition, Huajian Medical is expected to hold approximately 12.64% of the voting rights in Chuangye Huikang, assuming no further changes in the company's capital [1] Group 2 - This acquisition is aligned with national strategic guidance and reflects Huajian Medical's deep insight into the trends of the AI healthcare industry [2] - The investment is based on Huajian Medical's unique "K×A" intelligent capital model, targeting a leading company with strong innovation and industry presence [2] - The collaboration aims to create sustainable and substantial returns for both parties' shareholders and contribute to the advancement of China's healthcare sector [2]